• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSF3R基因的激活突变会引发遗传性慢性嗜中性粒细胞增多症。

An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.

作者信息

Plo Isabelle, Zhang Yanyan, Le Couédic Jean-Pierre, Nakatake Mayuka, Boulet Jean-Michel, Itaya Miki, Smith Steven O, Debili Najet, Constantinescu Stefan N, Vainchenker William, Louache Fawzia, de Botton Stéphane

机构信息

Research Laboratory on Hematopoiesis and Normal and Leukemic Stem Cells, U790, Institut National de la Santé et de la Recherche Médicale, 94805 Villejuif, France.

出版信息

J Exp Med. 2009 Aug 3;206(8):1701-7. doi: 10.1084/jem.20090693. Epub 2009 Jul 20.

DOI:10.1084/jem.20090693
PMID:19620628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2722170/
Abstract

We identify an autosomal mutation in the CSF3R gene in a family with a chronic neutrophilia. This T617N mutation energetically favors dimerization of the granulocyte colony-stimulating factor (G-CSF) receptor transmembrane domain, and thus, strongly promotes constitutive activation of the receptor and hypersensitivity to G-CSF for proliferation and differentiation, which ultimately leads to chronic neutrophilia. Mutant hematopoietic stem cells yield a myeloproliferative-like disorder in xenotransplantation and syngenic mouse bone marrow engraftment assays. The survey of 12 affected individuals during three generations indicates that only one patient had a myelodysplastic syndrome. Our data thus indicate that mutations in the CSF3R gene can be responsible for hereditary neutrophilia mimicking a myeloproliferative disorder.

摘要

我们在一个患有慢性中性粒细胞增多症的家族中鉴定出CSF3R基因的常染色体突变。这种T617N突变在能量上有利于粒细胞集落刺激因子(G-CSF)受体跨膜结构域的二聚化,因此,强烈促进受体的组成性激活以及对G-CSF增殖和分化的超敏反应,最终导致慢性中性粒细胞增多症。在异种移植和同基因小鼠骨髓移植试验中,突变的造血干细胞产生了类似骨髓增殖性疾病的病症。对三代中的12名受影响个体的调查表明,只有一名患者患有骨髓增生异常综合征。因此,我们的数据表明,CSF3R基因的突变可能是导致模仿骨髓增殖性疾病的遗传性中性粒细胞增多症的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/153e41218999/JEM_20090693_GS_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/6a0477e0f1f2/JEM_20090693_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/096b732854b5/JEM_20090693_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/3bd550d28c04/JEM_20090693_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/153e41218999/JEM_20090693_GS_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/6a0477e0f1f2/JEM_20090693_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/096b732854b5/JEM_20090693_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/3bd550d28c04/JEM_20090693_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece8/2722170/153e41218999/JEM_20090693_GS_Fig4.jpg

相似文献

1
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.CSF3R基因的激活突变会引发遗传性慢性嗜中性粒细胞增多症。
J Exp Med. 2009 Aug 3;206(8):1701-7. doi: 10.1084/jem.20090693. Epub 2009 Jul 20.
2
Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.粒细胞集落刺激因子受体 (CSF3R) 中的功能获得性突变揭示了 CSF3R 激活的不同机制。
J Biol Chem. 2018 May 11;293(19):7387-7396. doi: 10.1074/jbc.RA118.002417. Epub 2018 Mar 23.
3
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.CSF3R T618I 突变导致小鼠发生致命性中性粒细胞肿瘤,对治疗性 JAK 抑制有反应。
Blood. 2013 Nov 21;122(22):3628-31. doi: 10.1182/blood-2013-06-509976. Epub 2013 Sep 30.
4
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.集落刺激因子3受体T640N突变具有致癌性,对JAK抑制敏感,并模拟T618I。
Clin Cancer Res. 2016 Feb 1;22(3):757-64. doi: 10.1158/1078-0432.CCR-14-3100. Epub 2015 Oct 16.
5
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.T618I 突变在集落刺激因子 3 受体 (CSF3R) 蛋白中的配体独立性是由于 O-连接糖基化的丧失和受体二聚化增加所致。
J Biol Chem. 2014 Feb 28;289(9):5820-7. doi: 10.1074/jbc.M113.508440. Epub 2014 Jan 8.
6
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.严重先天性中性粒细胞减少症中CSF3R突变的发生率及其与白血病发生的相关性:一项长期调查结果
Blood. 2007 Jan 1;109(1):93-9. doi: 10.1182/blood-2006-02-004275. Epub 2006 Sep 19.
7
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.杂合子种系CSF3R变异作为血液系统恶性肿瘤发生的风险等位基因。
Blood Adv. 2020 Oct 27;4(20):5269-5284. doi: 10.1182/bloodadvances.2020002013.
8
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.CSF3R T618I 是慢性中性粒细胞白血病中一种高度普遍且特异性的突变。
Leukemia. 2013 Sep;27(9):1870-3. doi: 10.1038/leu.2013.122. Epub 2013 Apr 22.
9
Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.重组鼠粒细胞巨噬细胞集落刺激因子对外周血和骨髓的血液学影响。
Am J Pathol. 1990 Aug;137(2):369-76.
10
G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells.粒细胞集落刺激因子的应用有利于自体外周血造血祖细胞移植受者的 SDF-1 释放和中性粒细胞与单核细胞的激活。
Cytokine. 2019 Apr;116:38-47. doi: 10.1016/j.cyto.2018.12.011. Epub 2019 Jan 24.

引用本文的文献

1
The spectrum of Ph-negative disease: CNL and CSF3R-related disorders.Ph阴性疾病谱:慢性中性粒细胞白血病及CSF3R相关疾病
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):270-278. doi: 10.1182/hematology.2024000555.
2
Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins.骨髓增殖性肿瘤:由信号转导子和转录激活子(STAT)蛋白的慢性激活介导的疾病
Cancers (Basel). 2024 Jan 11;16(2):313. doi: 10.3390/cancers16020313.
3
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.

本文引用的文献

1
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity.JAK2V617F阳性骨髓增殖性疾病的造血干细胞区室反映了疾病的异质性。
Blood. 2008 Sep 15;112(6):2429-38. doi: 10.1182/blood-2008-02-137877. Epub 2008 Jul 8.
2
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition.原发性骨髓纤维化中MPL的新突变:只有MPL W515突变促进G1/S期转换。
Leukemia. 2008 Aug;22(8):1557-66. doi: 10.1038/leu.2008.137. Epub 2008 Jun 5.
3
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.
当单克隆丙种球蛋白病相关的慢性中性粒细胞白血病是一种与克隆性骨髓增殖性肿瘤不同的反应性过程时:从错误中吸取的教训。
EJHaem. 2023 May 19;4(3):823-826. doi: 10.1002/jha2.713. eCollection 2023 Aug.
4
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.ANKRD26 是正常和病理造血中 I 型细胞因子受体信号的新调节剂。
Haematologica. 2023 Aug 1;108(8):2130-2145. doi: 10.3324/haematol.2022.282049.
5
A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemia.在一名慢性嗜中性粒细胞白血病患者中鉴定出一种新型集落刺激因子3受体激活突变。
Haematologica. 2023 Jul 1;108(7):1945-1950. doi: 10.3324/haematol.2022.281828.
6
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.共同发生 CSF3R W791* 胚系和体细胞 T618I 驱动突变诱导早幼粒细胞白血病和混合表型急性白血病的克隆进展。
Curr Oncol. 2022 Feb 1;29(2):805-815. doi: 10.3390/curroncol29020068.
7
A novel activating JAK1 mutation in chronic eosinophilic leukemia.一种新型慢性嗜酸性白血病 JAK1 激活突变。
Blood Adv. 2021 Sep 28;5(18):3581-3586. doi: 10.1182/bloodadvances.2021004237.
8
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.CSF3R T618I突变型慢性粒单核细胞白血病(CMML)定义了一种增殖性CMML亚型,其富含ASXL1突变且预后不良。
Blood Cancer J. 2021 Mar 11;11(3):54. doi: 10.1038/s41408-021-00449-9.
9
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.杂合子种系CSF3R变异作为血液系统恶性肿瘤发生的风险等位基因。
Blood Adv. 2020 Oct 27;4(20):5269-5284. doi: 10.1182/bloodadvances.2020002013.
10
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.唐氏综合征患儿骨髓性前期白血病向转化性骨髓性白血病进展的机制。
Cancer Cell. 2019 Aug 12;36(2):123-138.e10. doi: 10.1016/j.ccell.2019.06.007. Epub 2019 Jul 11.
粒细胞集落刺激因子:稳态和“应急”造血过程中的分子作用机制
Cytokine. 2008 Jun;42(3):277-88. doi: 10.1016/j.cyto.2008.03.002. Epub 2008 Apr 8.
4
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.小鼠中的Csf3r突变通过激活Stat5赋予强大的克隆性造血干细胞优势。
J Clin Invest. 2008 Mar;118(3):946-55. doi: 10.1172/JCI32704.
5
A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy.
Leukemia. 2008 Feb;22(2):434-7. doi: 10.1038/sj.leu.2404906. Epub 2007 Sep 13.
6
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.严重先天性中性粒细胞减少症中CSF3R突变的发生率及其与白血病发生的相关性:一项长期调查结果
Blood. 2007 Jan 1;109(1):93-9. doi: 10.1182/blood-2006-02-004275. Epub 2006 Sep 19.
7
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.家族性原发性血小板增多症与c-MPL基因的显性阳性激活突变相关,该基因编码血小板生成素的受体。
Blood. 2004 Jun 1;103(11):4198-200. doi: 10.1182/blood-2003-10-3471. Epub 2004 Feb 5.
8
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.促红细胞生成素受体二聚体跨膜结构域和胞质结构域的活性与非活性取向。
Mol Cell. 2003 Nov;12(5):1239-50. doi: 10.1016/s1097-2765(03)00389-7.
9
Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells.功能性CD5⁺ B细胞主要在移植了人脐带血、骨髓或动员外周血CD34⁺细胞的NOD/SCID/γc(无)(NOG)小鼠脾脏中发育。
Exp Hematol. 2003 Sep;31(9):789-97. doi: 10.1016/s0301-472x(03)00193-0.
10
Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.髓系白血病患者中EVI1及其假定拮抗剂MDS1/EVI1表达的定量比较。
Genes Chromosomes Cancer. 2003 Jan;36(1):80-9. doi: 10.1002/gcc.10144.